As more bio-technology and life sciences organizations look to reap the operational and cost-savings benefits that a transition to cloud computing can offer, the risk to their organization increases exponentially. The protection of critical scientific intellectual property (IP) as it leaves the perimeter of the development organization into the “hands” of a third-party custodian becomes paramount. Putting IP research “into the cloud” poses data integrity, authenticity and ownership concerns if essential security controls are not in place.
Executives of R&D-based organizations have a fiduciary responsibility to maximize and protect the value of their company’s assets. Intangible assets drive nearly 70 percent of a bio-technology company’s market value, predominantly in the form of scientific IP. There are documented cases in which a company’s loss of intellectual property, either to a competitor or to the public domain, has led to hundreds of millions of dollars in lost revenue, legal fees, reduced market valuations and damages related to class-action lawsuits.
Truly innovative life sciences and bio-technology companies making the move to the cloud take scientific intellectual property protection seriously, and integrate data-level security controls, such as trusted third-party timestamping, into their electronic lab informatics systems and workflows. They understand that litigation-readiness is a critical part of the IP protection process, and that having the power of proof is an essential safeguard in winning a future patent or legal challenge. Associated with cloud computing is the concept of “chain-of-custody” and being able to legally defend “time-of-creation” and ownership of scientific intellectual property as it changes hands is of utmost importance.
As R&D organizations move to the cloud, they should mitigate the risk of losing scientific intellectual property. The best way to mitigate this risk is to put in place security controls that enable the company to validate the integrity and prove the authenticity of the electronic lab data it needs to support its scientific intellectual property claims. Such controls can prevent these files from being successfully challenged and eliminated as evidence, and can stand up and successfully be defended in terms of “ownership.” For the cloud services provider, integrating these data integrity protection controls, as well as a legally defensible “guarantee” into its own cloud service platform can offer key competitive differentiators over other providers in the market.
Surety’s AbsoluteProof is a third-party, trusted timestamping solution that when integrated into a company’s electronic lab informatics management processes or into a cloud service provider’s platform, enables the organization to prove, independently of their people, processes and systems that the scientific records have never been manipulated since the time they were created, “signed and sealed.” Surety is the only trusted timestamp authority that guarantees the legal defensibility of its service.
– Bob Flinton, Vice President of Marketing and Product Management, Surety
Surety LLC, along with Adobe Systems, Inc., Docusign, Inc., Simplifile, LC and Tru-Dataintegrity, will be presenting its electronic record integrity protection solutions at the 2010 Uniform Law Commission Annual Meeting in Chicago this weekend. The Electronic Technology Demonstrations event will take place on July 10 from 8:00 a.m. – 5:00 p.m. at the Palmer House Hilton. Surety executives will be on hand throughout the day to discuss with attendees the importance of electronic data integrity protection and demonstrate to you the ways in which Surety’s “Sign and Seal” digital timestamping tools are able to protect, defend and authenticate electronic records and other critical intellectual property files.
For more information about the event, visit www.nccusl.org. If you are interested in learning more about digital timestamping tools and how they can record the exact date, time and form in which an electronic document existed in, feel free to let us know. We’ll be happy to have a conversation with you about IP and electronic records protection and the tools you need to secure your most valuable electronic assets.
We look forward to meeting with you!
The summertime brings about travel, and that’s just what we here at Surety will be doing this summer. Our executives will be hitting the road and attending a variety of biotech events, addressing topics ranging from pharmaceutical technologies to manufacturing techniques. Take a look at your schedule and see if you can meet up with us. We’d love to see you out and about and discuss with us the importance of data integrity solutions and best practices for intellectual property protection.
Global Pharma Manufacturing Summit
June 14 – 15, 2010
Pharma Innovations Summit
July 27 – 28, 2010
When: Wednesday, April 21st, 2010 from 6:00 p.m. to 7:30 p.m. (iPad drawing at 7:15 p.m.)Where: Renaissance Marriott Hotel, 606 Congress StreetBoston, MA 02210, Spectacle Room, 4th FloorWhat: Cocktails, hors d’oeuvres, and demosLearn more:
If you’re involved in the intellectual property protection process at a pharmaceutical lab, you won’t want to miss a free upcoming webcast hosted by Surety, LLC and Pharmaceutical Technology. Led by Surety’s Bob Flinton, “Protect IP and Reduce the “Sign and Witness” Burden in Lab Informatics Processes”, will take place on Tuesday, March 9 at 11:00 a.m. EST.
The event will address the importance, challenges and process of protecting the authenticity and ownership of intellectual property (IP) within the bio-pharma industry. Flinton will discuss digital timestamping solutions and the way in which they can seamlessly be integrated into workflow processes and electronic lab informatics systems. Best practices will be shared, including time and cost-saving measures that data integrity protection solutions can bring to the scientific community, making the “sign and witness” process more efficient.
WHAT: Complimentary webcast hosted by Surety, LLC and Pharmaceutical Technology – “Protect IP and Reduce the “Sign and Witness” Burden in Lab Informatics Processes”
WHO: Speaker – Bob Flinton, Vice President of Marketing and Project Management, Surety, LLC Moderator – Michelle Hoffman, Editor in Chief, Pharmaceutical Technology Magazine
WHEN: Tuesday, March 9 at 11:00 a.m. EST
REGISTRATION: Interested attendees can register here for free
Surety announced today that Ansaris, a drug discovery and development company, has selected AbsoluteProof to legally protect the authenticity and integrity of its lab’s critical data.
Ansaris is a drug-discovery company focused on solving small-molecule challenges by utilizing its proprietary technology platform. The company integrates fragment-based drug design, protein modelling and medicinal chemistry and biology expertise to identify novel therapeutics. Critical to the drug-discovery process is the ability to prove “time of invention” in order to protect intellectual property that is generated.
“Prior to implementing AbsoluteProof, we required scientists to save their experiments to DVD, and then have them physically signed, countersigned and witnessed,” said Joan Lau, President and CEO, Ansaris. “This process was labor-intensive and time consuming. Considering that only 20 percent of our industry has a purely electronic solution for archival, our challenge was to design and implement a lab informatics solution that could satisfy the requirements of proving inventorship.”
Read the full press release here.